Skip to content
OpenCapital
Get started

Cumberland Pharmaceuticals CPIX Omeclamox-Pak — Revenues, including adjustments

Similar metrics at other companies

Incyte logo
INCYOPZELURA — Total revenues
$143.02M+20.5%
Incyte logo
INCYPEMAZYRE — Total revenues
$22.54M+22.3%
Bristol-Myers Squibb logo
BMYNet product sales — Total Revenues
$11.17B+2.6%
Regeneron Pharmaceuticals logo
REGNProduct — Revenue
$1.53B+8.4%
Esperion Therapeutics logo
ESPRProduct sales, net — Total Revenues
$43.4M+24.3%
Tarsus Pharmaceuticals, Inc. logo
TARSProduct sales, net — Total revenues
$145.39M+85.6%

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+138%
Enterprise value$90.91M+207%
P/S2.3×+1.3×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%—

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept cpix:RevenueFromContractWithCustomerExcludingAssessedTaxIncludingAdjustments.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's omeclamox-pak — revenues, including adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's omeclamox-pak — revenues, including adjustments?
Cumberland Pharmaceuticals (CPIX) reported omeclamox-pak — revenues, including adjustments of $1 in Q1 2026.
How has Cumberland Pharmaceuticals's omeclamox-pak — revenues, including adjustments changed year-over-year?
Cumberland Pharmaceuticals's omeclamox-pak — revenues, including adjustments increased by 100.0% year-over-year, from -$5.39K to $1.
What does omeclamox-pak — revenues, including adjustments mean?
This metric represents the total net sales generated by a specific pharmaceutical product line after accounting for all relevant adjustments, such as returns, rebates, and discounts. It serves as a key indicator of the product's market performance and commercial viability within the company's specialty portfolio. By including these adjustments, the figure provides a more accurate reflection of the actual cash-generating capacity of the product.